Drug Shortage Report for IRBESARTAN
| Report ID | 108344 |
| Drug Identification Number | 02372398 |
| Brand name | IRBESARTAN |
| Common or Proper name | IRBESARTAN |
| Company Name | SANIS HEALTH INC |
| Market Status | MARKETED |
| Active Ingredient(s) | IRBESARTAN |
| Strength(s) | 300MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2020-07-28 |
| Actual start date | 2020-08-04 |
| Estimated end date | 2021-08-22 |
| Actual end date | 2021-09-13 |
| Shortage status | Resolved |
| Updated date | 2021-09-14 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v18 | 2021-09-14 | English | Compare |
| v17 | 2021-09-13 | French | Compare |
| v16 | 2021-09-13 | English | Compare |
| v15 | 2021-08-03 | French | Compare |
| v14 | 2021-08-03 | English | Compare |
| v13 | 2021-07-05 | French | Compare |
| v12 | 2021-07-05 | English | Compare |
| v11 | 2021-04-19 | French | Compare |
| v10 | 2021-04-19 | English | Compare |
| v9 | 2020-08-05 | English | Compare |
| v8 | 2020-08-04 | French | Compare |
| v7 | 2020-08-04 | English | Compare |
| v6 | 2020-07-29 | English | Compare |
| v5 | 2020-05-04 | French | Compare |
| v4 | 2020-05-04 | English | Compare |
| v3 | 2020-04-30 | English | Compare |
| v2 | 2020-03-10 | French | Compare |
| v1 | 2020-03-10 | English | Compare |
Showing 1 to 18 of 18